The new Clinical Trial Regulation and corresponding …

CAP Centrally Authorised Product . CEN Comité Européen de Normalisation, European Committee for Standardisation . CENELEC Comité Européen de Normalisation Électrotechnique, European Committee for

  Product

Labelling Requirements for Investigational …

Labelling Requirements for Investigational Medicinal Products in Multinational Clinical Trials: Bureaucratic Cost Driver or Added Value? Wissenschaftliche Prüfungsarbeit

  Medicinal, Investigational, Investigational medicinal

Forced degradation studies – comparison between …

Forced degradation studies – comparison between ICH, EMA, FDA and WHO guidelines and ANVISA’s resolution RDC 53/2015 Wissenschaftliche Prüfungsarbeit

  Forced

Best practice of worldwide product variations …

Best practice of worldwide product variations regarding planning, conduct and implementation Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels

Regulatory requirements of Medical Devices in …

VII List of Abbreviations AHWP Asian Harmonization Working Party AMC Authorization for Market Commercialization APEC Asia Pacific Economic Cooporation

  Market

Standard for Outcome Measures in Clinical Trials for …

Standard for Outcome Measures in Clinical Trials for the treatment of plaque psoriasis supporting Labelling Claim and their application in practice

Global Development Strategy for Generic Medicinal …

Global Development Strategy for Generic Medicinal Products with Regard to Bioequivalence Studies – Special Focus on the Biowaiver Approach in Canada, Australia and Brazil

  Studies, Bioequivalence, Bioequivalence studies

Animal Health market in the BRIC countries and …

List of Abbreviations 1 List of Abbreviations ACFTA ASEAN-China Free Trade Agreement AH Animal Health

  Trade

EMA versus US-FDA regulatory requirements …

EMA versus US-FDA regulatory requirements regarding bioequivalence of orally administered generics Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels "Master of Drug Regulatory Affairs"

  Requirements, Regulatory, Versus, Ema versus us fda regulatory requirements

Development of Generic Oral Human Medicinal …

Development of Generic Oral Human Medicinal Products Suitable for the Registration in the EU as well as the USA – Different Requirements, Feasibility, Time and Cost

Guideline on good pharmacovigilance practices (GVP)

VIII.C.1. Procedure for imposing post-authorisation safety studies ..... 18 VIII.C.1.1. Request for a post-authorisation safety study as part of the initial marketing

  Marketing, Authorisation

EU COMMUNITY REGISTER OF MEDICINAL …

contents eu community register of medicinal products - frequently asked questions..... 1 what is a marketing authorisation?

  Product, Question, Marketing, Frequently, Asked, Medicinal, Registers, Authorisation, Register of medicinal, Register of medicinal products frequently asked questions, Marketing authorisation

CMD(h) BEST PRACTICE GUIDE ON THE …

BPG on the Processing of Renewals in the Mutual Recognition and Decentralised Procedures Rev.5, November 2008 Page 2/11 The principle applies that the marketing authorisation holder may apply for a renewal earlier than

  Marketing, Procedures, Mutual, Recognition, Authorisation, Decentralised, The mutual recognition and decentralised procedures, Marketing authorisation

BEST PRACTICE GUIDE For Type IB Variations …

1.5 A marketing authorisation holder (MAH) may also submit several Type IB and/or Type II variations to one or more of their products in a single

  Marketing, Authorisation, Marketing authorisation

2005 12 14 Annex 19 Final - Trends

5 10. Reference and Retention Samples in the Case of Closedown of a Manufacturer 10.1 Where a manufacturer closes down and the manufacturing authorisation is surrendered, re-

  Authorisation

Guideline on the processing of renewals in the …

EMEA/CHMP/2990/00 Rev.5 Guideline on the processing of renewals in the centralised procedure Page 5/20 In any case, in accordance with Article 16(3) of Regulation (EC) No 726/2004, the marketing

  Marketing

Guidance for Applicants for the Early Access to …

April 2014 Page 1 Guidance for Applicants for the Early Access to Medicines Scheme (EAMS) - Step II . The Early Access to Medicines Scheme (EAMS) aims to give patients access to medicines that do not

  Access, Medicine, Early, Schemes, Emas, Early access to medicines scheme

NEW ZEALAND DATA SHEET 1. FLUCLOXACILLIN 2. …

Page 3 of 11 Flucloxacillin is contraindicated in patients with a previous history of flucloxacillin-associated jaundice/hepatic dysfunction.

  Flucloxacillin

Package leaflet: Information for the patient …

Package leaflet: Information for the patient Lactulose Solution Lactulose Read all of this leaflet carefully before you start taking this medicine because it contains

  Patients, Solutions, Lactulose, The patient lactulose solution lactulose